SOPHiA GENETICS SA (SOPH) Misses Q2 EPS by 4c

SOPHiA GENETICS SA (NASDAQ: SOPH) reported Q2 EPS of ($0.33), $0.04 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $15.1 million versus the consensus estimate of $15.24 million.

For earnings history and earnings-related data on SOPHiA GENETICS SA (SOPH) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• SpaceX receives Baa1 rating from Moody's with stable outlook
• Accenture (ACN) Tops Q3 EPS by 8c, Misses on Revenue; Offers FY26 EPS Guidance